Interestingly, despite the benefit of CD34+ve exosomes observed on angiogenesis, CD34+ve hematopoietic stem cells were not cardioprotective when administered after acute myocardial infarction unless engineered to express sonic hedgehog (Shh) [45]. This evidence concerns the gene CD34 and myocardial infarction.